Inhibitory effect of capsaicin on B16-F10 melanoma cell migration via the phosphatidylinositol 3-kinase/Akt/Rac1 signal pathway

Capsaicin ( trans -8-methyl- N -vanillyl-6-nonenamide), the major pungent ingredient of red pepper, has been reported to possess anti-carcinogenic and anti-mutagenic activities. In this study, the anti-migration activity of capsaicin on highly metastatic B16-F10 melanoma cells was investigated. Caps...

Full description

Saved in:
Bibliographic Details
Published inExperimental & molecular medicine Vol. 40; no. 5; pp. 486 - 494
Main Authors Shin, Dong-Hoon, Kim, Ok-Hee, Jun, Hye-Seung, Kang, Mi-Kyung
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 31.10.2008
Springer Nature B.V
Korean Society of Medical Biochemistry and Molecular Biology
생화학분자생물학회
Subjects
Online AccessGet full text
ISSN1226-3613
2092-6413
DOI10.3858/emm.2008.40.5.486

Cover

More Information
Summary:Capsaicin ( trans -8-methyl- N -vanillyl-6-nonenamide), the major pungent ingredient of red pepper, has been reported to possess anti-carcinogenic and anti-mutagenic activities. In this study, the anti-migration activity of capsaicin on highly metastatic B16-F10 melanoma cells was investigated. Capsaicin significantly inhibited the migration of melanoma cells without showing obvious cellular cytotoxicity at low doses. This effect correlated with the down-regulation of phosphatidylinositol 3-kinase (PI3-K) and its downstream target, Akt. Although B16-F10 cell migration was increased by the PI3-K activator through the activation of Akt, these PI3-K activator-induced phenomena were attenuated by capsaicin. Moreover, capsaicin was found to significantly inhibit Rac1 activity in a pull-down assay. These results demonstrate that capsaicin inhibits the migration of B16-F10 cells through the inhibition of the PI3-K/Akt/Rac1 signal pathway. The present investigation suggests that capsaicin targets PI3-K/Akt/Rac1-mediated cellular events in B16-F10 melanoma cells. Consequently, capsaicin administration should be considered an effective approach for the suppression of invasion and metastasis in malignant melanoma chemotherapy.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
G704-000088.2008.40.5.004
http://kmbase.medric.or.kr/Main.aspx?d=KMBASE&m=VIEW&i=0620920080400050486
ISSN:1226-3613
2092-6413
DOI:10.3858/emm.2008.40.5.486